You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. HUMAN MONOCOLONAL ANTIBODIES FOR CNS REMYELINATION

    SBC: Acorda Therapeutics, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The primary goal of the current research will be to select the best recombinant form of one of two naturally occurring human igM antibodies demonstrated to stimulate remyelination to further develop for clinical testing in inflammatory demyelinating disease, such as MS. These antibodies, designated sHIgM22 and sHIgM46, were isolated by the Rodriquez laboratory ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  2. CHROMOGENIC HER-2/NEU GENE AMPLIFICATION ASSAY

    SBC: NANOPROBES INC            Topic: N/A

    Overexpression of the Her-2/neu protein and amplification of the Her-2/neu gene are are the most widely accepted prognostic indicator of aggressive malignant behavior of invasive breast carcinoma. Accurate detection of Her-2/neu overexpression is critical in identifying patients suitable for serotherapy with humanized monoclonal antibody (Herceptin). Fluorescence in situ hybridization (FISH) has b ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  3. DRIVING SIMULATOR FOR PERSONS WITH IMPAIRED COGNITION

    SBC: Systems Technology, Inc.            Topic: N/A

    Brain injury frequently results in cognitive impairment reducing an individual?s ability to judge driving situations accurately. Rehabilitation professionals use on-road tests to determine if an individual is safe to drive, but these tests are typically performed under calm conditions and offer little information on the individual?s responses to typical, real-life driving challenges. STISIM is a r ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  4. ULTRASENSITIVE METHODS FOR HUMAN BIOMARKER QUANTITATION

    SBC: TRIANGLE LABORATORIES, INC.            Topic: N/A

    Basic research aimed at understanding the complex regulations and interactions lead to various diseases requires novel bioanalytical approaches that allow detailed characterization of the proteome with ultra high-speed and sensitivity so that important regulatory proteins can be effectively studied. For the analysis of complex protein mixtures such as cell lysates, two-dimensional polyacrylamide g ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  5. ASSAYS FOR ROS-INDUCED DNA DAMAGE

    SBC: ZEPTOMETRIX CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant):This project is a collaboration between ZeptoMetrix Corporation and Roswell Park Cancer Institute. The objective is to develop sensitive, quantitative and facile assays for measuring DNA damage caused by reactive oxygen species (ROS). ROS have been implicated in aging, cancer and several neurological diseases. Seven ROS-induced DNA lesions will be assayed, namel ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  6. HIGH THROUGHPUT GENOTYPING TECHNOLOGY

    SBC: PARALLELE BIOSCIENCE, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): There is a need for inexpensive high throughput platforms for analyzing large number of single nucleotide polymorphisms. In this proposal, we describe the development of a technique, which will enable more than 10,000 SNPs to be analyzed in a single tube and its transfer to a commercial entity (ParAllele Genomcis Inc.). T ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  7. ANTI-ANDROGENIC MECHANISM OF A NEW COMPOUND

    SBC: ANDROSCIENCE CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Androgen blockage therapy may relieve the symptom of an advanced, localized prostate tumor; however, once the tumor evolves into a hormone-refractory stage, there is no effective treatment. A continuous activation of AR by antiandrogens (used in androgen blockage therapy) or other "nonconventional" agonists may contribute to prostate cancer progression in patie ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  8. DEVELOPMENT OF A NEW TREATMENT OF URINARY STONE DISEASE

    SBC: BIOSTRATUM, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Development of a new method for prophylaxis and treatment of urinary stone disease is proposed. Since a majority of urinary stones are made of calcium oxalate, the level of urinary oxalate is one of the major risk factors of stone formation. Unfortunately, there is no effective pharmacological treatment of stone disease that targets urinary oxalate concentratio ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  9. ENDOVASCULAR EMBOLECTOMY FOR STROKE- EXPERIMENTAL STUDY

    SBC: CONCENTRIC-MEDICAL            Topic: N/A

    DESCRIPTION (Adapted from applicant's abstract): The application's long-term objective is to improve the treatment of acute ischemic stroke by using mechanical embolectomy for arterial recanalization. The specific aim of this project is to design and test various versions of the Clot Retriever Device (CRD), a helix shaped nitinol device made to ensnare and retrieve thrombo-emboli from cerebral art ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  10. AUTOMATED SYNTHESIS OF F-18 FLUOROCHOLINE

    SBC: TRACERA, LLC            Topic: N/A

    Improved imaging technologies are critically needed for noninvasive detection of cancer. We have recently shown excellent imaging feasibility of prostate cancer, breast cancer and brain tumors using F-1 8 labeled choline (FCH) and positron emission tomography (PET). In order to minimize radiation exposure to radiochemistry personnel and increase th; reliability of radiotracer synthesis, it is prop ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government